Oyster Point Pharma, Inc.: 25-NSE filed Jan 3, 2023

Form type

25-NSE

Filing date

Jan 3, 2023

Accession number

0001354457-23-000001

Filer

Oyster Point Pharma, Inc. (CIK 1720725)